Adiponectin gene polymorphisms and susceptibility to diabetic nephropathy: a meta-analysis

References

• Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346(15):1145–1151
   PubMed Web of Science ®Google Scholar
• Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378(9786):182–197
   PubMed Web of Science ®Google Scholar
• Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism. 2011;60(1):1–23
   PubMed Web of Science ®Google Scholar
• Maeda S, Imamura M, Kurashige M, et al. Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes. Clin Exp Nephrol. 2013 . [Epub ahead of print]. doi: 10.1007/s10157-013-0797-5
   Google Scholar
• Yang S, Zhang J, Feng C, Huang G. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis. Metabolism. 2013;62(4):586–594
   PubMed Web of Science ®Google Scholar
• Sandholm N, Salem RM, McKnight AJ, et al. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet. 2012;8(9):e1002921
   PubMed Web of Science ®Google Scholar
• Karadeniz M, Erdogan M, Cetinkalp S, Berdeli A, Eroglu Z, Ozgen AG. Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy. Endocrine. 2010;37(3):513–517
   PubMedGoogle Scholar
• Vionnet N, Tregouët D, Kazeem G, et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes. 2006;55(11):3166–3174
   PubMedGoogle Scholar
• Zhang D, Ma J, Brismar K, Efendic S, Gu HF. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. J Diabetes Complications. 2009;23(4):265–272
   PubMedGoogle Scholar
• Zhang D, Efendic S, Brismar K, Gu HF. Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus. BMC Med Genet. 2010;11:116
   PubMed Web of Science ®Google Scholar
• Chu H, Wang M, Zhong D, et al. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. Diabetes Metab Res Rev. 2013;29(7):532–545
   PubMedGoogle Scholar
• Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes. 2005;54(5):1607–1610
   PubMedGoogle Scholar
• Francke S, Manraj M, Lacquemant C, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet. 2001;10(24):2751–2765
   PubMedGoogle Scholar
• Fumeron F, Aubert R, Siddiq A, et al. Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group: adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes. 2004;53(4):1150–1157
   PubMedGoogle Scholar
• Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 2007;56(5):1198–1209
   PubMed Web of Science ®Google Scholar
• Jaziri R, Aubert R, Roussel R, et al. Association of ADIPOQ genetic variants and plasma adiponectin isoforms with the risk of incident renal events in type 2 diabetes. Nephrol Dial Transplant. 2010;25(7):2231–2237
   PubMed Web of Science ®Google Scholar
• Choe EY, Wang HJ, Kwon O, et al. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes. Metabolism. 2013;62(5):677–685
   PubMed Web of Science ®Google Scholar
• Wu LS, Hsieh CH, Pei D, Hung YJ, Kuo SW, Lin E. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARgamma and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant. 2009;24(11):3360–3366
   PubMedGoogle Scholar
• Ma J, Möllsten A, Falhammar H, et al. Genetic association analysis of the adiponectin polymorphisms in type 1 diabetes with and without diabetic nephropathy. J Diabetes Complications. 2007;21(1):28–33
   PubMedGoogle Scholar
• Yoshioka K, Yoshida T, Umekawa T, et al. Adiponectin gene polymorphism (G276T) is not associated with incipient diabetic nephropathy in Japanese type 2 diabetic patients. Metabolism. 2004;53(9):1223–1226
   PubMedGoogle Scholar
• Blech I, Katzenellenbogen M, Katzenellenbogen A, et al. Predicting diabetic nephropathy using a multifactorial genetic model. PLoS One. 2011;6(4):e18743
   Google Scholar
• Ranjbar SH, Amoli MM, Sajadi M, et al. Genetic association analysis of the adiponectin polymorphisms in type 2 diabetes with and without complications. Iran J Diabetes Lipid Disord. 2011;10:1–4
   Google Scholar
• Guo Z, Wu S, Sun Y. Relationship between single nucleotide polymorphism at position 276 in adiponectin gene and type 2 diabetic nephropathy. J Shanxi Med Univ. 2008;39(6):507–510. [in Chinese]
   Google Scholar
• Min Y, Chen J, Zhu L, Li X, Wei J, Su K. Association of SNP-11377C/G in proximal promoter region of adiponectin gene with type 2 diabetic nephropathy. Shandong Med J. 2011;5:65–66. [in Chinese]
   Google Scholar
• Lin J, Shi Y, Li Y, Tao G. Association of gene polymorphism in promoter region of adiponectin gene and albuminuria in patients with type 2 diabetes mellitus. Chin J Diabetes Mellitus. 2010;2(2):106–110. [in Chinese]
   Google Scholar
• Peng C, Hong Y, Fu L. Association of adiponectin gene polymorphism in type 2 diabetes with nephropathy. J Med Res. 2012;41(4):156–159. [in Chinese]
   Google Scholar
• Bostrom MA, Freedman BI, Langefeld CD, Liu L, Hicks PJ, Bowden DW. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. Diabetes. 2009;58(2):499–504
   PubMedGoogle Scholar
• Prior SL, Javid J, Gill GV, Bain SC, Stephens JW. The adiponectin rs17300539 G > A variant and nephropathy risk. Kidney Int. 2008;74(10):1361
   PubMedGoogle Scholar
• Zhao H, Chen L, Zhang C, Han J. Polymorphism in the 5′promoter region of the APN gene contributes to development of type 2 diabetes nephropathy. Proc Clin Med. 2008;1(7):483–485. [in Chinese]
   Google Scholar
• Jia M, Feng X, Zhang Z, Qiao B, Qin X, Sun Y. Correlation of polymorphism of adiponectin promoter with diabetes type 2 and its complications. Chin J Lab Med. 2008;31(2):163–169. [in Chinese]
   Google Scholar
• Jorsal A, Tarnow L, Frystyk J, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008;74(5):649–654
   PubMedGoogle Scholar
• Rudofsky G Jr, Schlimme M, Schlotterer A, et al. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications. Diabetes Obes Metab. 2005;7(4):455–459
   PubMedGoogle Scholar
• Gu HF, Alvarsson A, Efendic S, Brismar K. SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study. Gend Med. 2009;6(4):555–564
   PubMedGoogle Scholar
• Gu HF. Biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. Biomark Insights. 2009;4:123–133
   PubMedGoogle Scholar
• Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560
   PubMed Web of Science ®Google Scholar
• Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–129
   Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188
   PubMedGoogle Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748
   PubMed Web of Science ®Google Scholar
• Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull. 1999;8:15–17
   Google Scholar
• Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316(7129):469--471
   Google Scholar
• Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol. 2011;11:41
   PubMed Web of Science ®Google Scholar
• Chung HF, Chen PS, Long K, Hsu CC, Huang MC. The association of ADIPOQ gene polymorphisms and clinical risk factors with nephropathy progression in type 2 diabetes. Meeting Abstracts. Experimental Biology 2012, EB, San Diego, CA, Apr 21–25, 2012
   Google Scholar
• Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant. 1989;4:859–863
   PubMed Web of Science ®Google Scholar
• Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes. Am J Kidney Dis. 2003;41(6):1189–1194
   PubMedGoogle Scholar
• Wang L, Teng Z, Cai S, Wang D, Zhao X, Yu K. The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects. Diagn Pathol. 2013;8(1):118 (1--7). doi: 10.1186/1746-1596-8-118
   PubMedGoogle Scholar
• Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. Am J Kidney Dis. 1995;25(5):710–713
   PubMedGoogle Scholar
• Österholm AM, He B, Pitkaniemi J, et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int. 2007;71(2):140–145
   PubMedGoogle Scholar
• Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol. 2007;2(6):1306–1316
   PubMed Web of Science ®Google Scholar
• McKillop AM, Flatt PR. Recent developments in the search for biomarkers for the diagnosis and monitoring of diabetes. Recent Pat Endocr Metab Immune Drug Discov. 2008;2(3):172–177
   Google Scholar
• Yamagishi SI, Fukami K, Ueda S, Okuda S. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets. 2007;8(8):952–959
   PubMed Web of Science ®Google Scholar
• Jee SH, Sull JW, Lee JE, et al. Adiponectin concentrations: a genome-wide association study. Am J Hum Genet. 2010;87(4):545–552
   PubMedGoogle Scholar
• Ling H, Waterworth DM, Stirnadel HA, et al. Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS Study. Obesity. 2009;17(4):737–744
   PubMedGoogle Scholar
• Richards JB, Waterworth D, O'Rahilly S, et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009;5(12):e1000768
   Google Scholar
• Heid IM, Wagner SA, Gohlke H, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes. 2006;55(2):375–384
   PubMedGoogle Scholar
• Laumen H, Saningong AD, Heid IM, et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes. 2009;58(4):984–991
   PubMedGoogle Scholar